Results 101 to 110 of about 8,113 (209)

Bladder Endothelin-1 Receptor Binding of Bosentan and Ambrisentan

Journal of Pharmacological Sciences, 2014
.: The present study aimed to characterize bladder endothelin-1 (ET-1) receptor binding of clinically used ET-1 receptor antagonists by using [125I]ET-1.
Ayaka Osano, Yoshinari Yokoyama, Hideki Hayashi, Kunihiko Itoh, Takashi Okura, Yoshiharu Deguchi, Yoshihiko Ito, Shizuo Yamada   +7 more
doaj  

Bosentan: a new therapy for Eisenmenger syndrome? [PDF]

, 2006

openalex   +1 more source

Long-term outcome and effects of oral bosentan therapy in Taiwanese patients with advanced idiopathic pulmonary arterial hypertension [PDF]

, 2007
Hsao‐Hsun Hsu, Jin‐Shing Chen, Robert J. Chen, Wen-Je Ko, Shuenn‐Wen Kuo, En‐Ting Wu, Mei‐Hwan Wu, Jou‐Kou Wang, Yung‐Chie Lee   +8 more
openalex   +1 more source

Results of European post-marketing surveillance of bosentan in pulmonary hypertension [PDF]

, 2007
Marc Humbert, Eleanor S Segal, David G. Kiely, Joern Carlsen, Barbara Schwierin, Marius M. Hoeper   +5 more
openalex   +1 more source

Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease [PDF]

, 2007
Gerhard‐Paul Diller, Konstantinos Dimopoulos, Mehmet Kaya, Carl Harries, Anselm Uebing, Wěi Li, Evdokia Koltsida, J. Simon R. Gibbs, M. A Gatzoulis   +8 more
openalex   +1 more source

Protective Effects of Bosentan via Endothelin Receptor Antagonism in Experimental Ischemia-Reperfusion Injury in the Lower Limb of Rats. [PDF]

Drug Des Devel Ther
Demirtaş H, Özer A, Gülcan MB, Yığman Z, Küçük A, Tekin E, Ünal Y, Dursun AD, Dağlı A, Arslan M.   +9 more
europepmc   +1 more source

Bosentan as adjunctive therapy in neonates with congenital diaphragmatic hernia-associated pulmonary hypertension: a case series. [PDF]

Eur J Pediatr
De Vadder A, Lemloh L, Bo B, Hale L, Patel N, Mueller A, Kipfmueller F.   +6 more
europepmc   +1 more source

Bosentan and losartan ameliorate acute renal failure associated with mild but not strong NO blockade [PDF]

, 2007
Zoran Miloradović, Mirjana Jerkić, Djurdjica Jovović, Nevena Mihailovic‐Stanojevic, Jelica Grujić-Milanović, Gordana Stošić, Jasmina Markovic‐Lipkovski   +6 more
openalex   +1 more source

Prolonged Prothrombin Time due to Drug-Drug Interaction of Warfarin after the Change from Bosentan to Macitentan: A Case of Pharmacist Intervention in the Outpatient Clinic. [PDF]

Kobe J Med Sci
Kurimura T, Omura T, Yamamoto K, Tanaka H, Kimura T, Itohara K, Kitahiro Y, Habu Y, Sakane T, Yano I.   +9 more
europepmc   +1 more source

[Pharmacological characteristics and clinical efficacy of bosentan].

, 2005
Kazumi Fujimoto, Satoru Ikenoya
openalex   +2 more sources